×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

Open China market to Indian IT, pharma: Montek

Open China market to Indian IT, pharma: Montek
Comment E-mail Print Share
First Published: Mon, Sep 26 2011. 02 53 PM IST
Updated: Mon, Sep 26 2011. 02 53 PM IST
Beijing: The government on Monday urged China to open its huge markets to Indian IT and pharma products to bring about balance in bilateral trade.
“I believe the Chinese side is aware of our market access concerns,” said Planning Commission deputy chairman Montek Singh Ahluwalia at the first Strategic Economic Dialogue (SED) between the two countries here.
Praising the giant strides made by China in its economic development, he said that India looks to China to open its markets for IT and pharma.
“Taking a strategic view of our relationship, I hope that they would consider a more positive approach in sectors like IT and pharmaceuticals, where I believe India’s competitiveness is not in doubt, and where there is great unrealised potential,” said Ahluwalia.
Although the bilateral trade crossed $61 billion this year, India was left with deficit of over $40.9 billion due to accelerated exports from China.
Besides pressing China to open its IT and pharmaceutical market, which Indian official think holds huge potential, India also conducted high voltage campaigns to raise awareness in China about the strides Indian companies made in the two sectors.
“This will not only help project our overall economic partnership as a win-win situation but give Chinese companies more options in their own growth trajectory,” Ahluwalia argued.
“I would encourage our Chinese colleagues to be equally candid about expressing their concerns. Both sides should discuss ways of improving the investment climate as that is essential to raise our economic relationship to a higher level,” he added.
Comment E-mail Print Share
First Published: Mon, Sep 26 2011. 02 53 PM IST
More Topics: China | Montek | Planning Commission | IT | Pharma |